SIRT1 and gastric cancer: In research focused on gastric cancer (GC), the use of SIRT1 activator resveratrol (RSV) resulted in a significant reduction in STAT3 and c-myc gene expression as well as the expression of phosphorylated (STAT3-P) and acetylated (STAT3-Ac) forms of STAT3.